DE3490215T - Verfahren zur Herstellung von 1α,25-dihydroxyliertem Vitamin D↓2↓ und verwandten Verbindungen - Google Patents

Verfahren zur Herstellung von 1α,25-dihydroxyliertem Vitamin D↓2↓ und verwandten Verbindungen

Info

Publication number
DE3490215T
DE3490215T DE19843490215 DE3490215T DE3490215T DE 3490215 T DE3490215 T DE 3490215T DE 19843490215 DE19843490215 DE 19843490215 DE 3490215 T DE3490215 T DE 3490215T DE 3490215 T DE3490215 T DE 3490215T
Authority
DE
Germany
Prior art keywords
vitamin
compound
dihydroxy
trans
dihydroxyvitamin
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Pending
Application number
DE19843490215
Other languages
German (de)
English (en)
Other versions
DE3490215C2 (enExample
Inventor
Hector F. Deluca
Heinrich K. Madison Wis. Schnoes
Rafal R. Warschau/Warszawa Sicinski
Yoko Madison Wis. Tanaka
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Wisconsin Alumni Research Foundation
Original Assignee
Wisconsin Alumni Research Foundation
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Wisconsin Alumni Research Foundation filed Critical Wisconsin Alumni Research Foundation
Publication of DE3490215T publication Critical patent/DE3490215T/de
Pending legal-status Critical Current

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07C—ACYCLIC OR CARBOCYCLIC COMPOUNDS
    • C07C401/00—Irradiation products of cholesterol or its derivatives; Vitamin D derivatives, 9,10-seco cyclopenta[a]phenanthrene or analogues obtained by chemical preparation without irradiation
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P13/00—Drugs for disorders of the urinary system
    • A61P13/02—Drugs for disorders of the urinary system of urine or of the urinary tract, e.g. urine acidifiers
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P15/00—Drugs for genital or sexual disorders; Contraceptives
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P3/00—Drugs for disorders of the metabolism
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P3/00—Drugs for disorders of the metabolism
    • A61P3/02—Nutrients, e.g. vitamins, minerals
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P3/00—Drugs for disorders of the metabolism
    • A61P3/12—Drugs for disorders of the metabolism for electrolyte homeostasis
    • A61P3/14—Drugs for disorders of the metabolism for electrolyte homeostasis for calcium homeostasis
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D317/00—Heterocyclic compounds containing five-membered rings having two oxygen atoms as the only ring hetero atoms
    • C07D317/08—Heterocyclic compounds containing five-membered rings having two oxygen atoms as the only ring hetero atoms having the hetero atoms in positions 1 and 3
    • C07D317/10—Heterocyclic compounds containing five-membered rings having two oxygen atoms as the only ring hetero atoms having the hetero atoms in positions 1 and 3 not condensed with other rings
    • C07D317/14—Heterocyclic compounds containing five-membered rings having two oxygen atoms as the only ring hetero atoms having the hetero atoms in positions 1 and 3 not condensed with other rings with substituted hydrocarbon radicals attached to ring carbon atoms
    • C07D317/18—Radicals substituted by singly bound oxygen or sulfur atoms
    • C07D317/24—Radicals substituted by singly bound oxygen or sulfur atoms esterified
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07J—STEROIDS
    • C07J71/00—Steroids in which the cyclopenta(a)hydrophenanthrene skeleton is condensed with a heterocyclic ring
    • C07J71/0036—Nitrogen-containing hetero ring
    • C07J71/0042—Nitrogen only

Landscapes

  • Health & Medical Sciences (AREA)
  • Organic Chemistry (AREA)
  • Chemical & Material Sciences (AREA)
  • General Health & Medical Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Animal Behavior & Ethology (AREA)
  • Engineering & Computer Science (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • General Chemical & Material Sciences (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Hematology (AREA)
  • Obesity (AREA)
  • Diabetes (AREA)
  • Endocrinology (AREA)
  • Rheumatology (AREA)
  • Nutrition Science (AREA)
  • Urology & Nephrology (AREA)
  • Reproductive Health (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Organic Low-Molecular-Weight Compounds And Preparation Thereof (AREA)
  • Steroid Compounds (AREA)
DE19843490215 1983-05-09 1984-05-09 Verfahren zur Herstellung von 1α,25-dihydroxyliertem Vitamin D↓2↓ und verwandten Verbindungen Pending DE3490215T (de)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
US49286383A 1983-05-09 1983-05-09
US60732784A 1984-05-04 1984-05-04

Publications (1)

Publication Number Publication Date
DE3490215T true DE3490215T (de) 1985-05-15

Family

ID=27050897

Family Applications (4)

Application Number Title Priority Date Filing Date
DE19843490215 Pending DE3490215T (de) 1983-05-09 1984-05-09 Verfahren zur Herstellung von 1α,25-dihydroxyliertem Vitamin D↓2↓ und verwandten Verbindungen
DE3448412A Expired - Lifetime DE3448412C2 (enExample) 1983-05-09 1984-05-09
DE3448360A Expired - Lifetime DE3448360C2 (enExample) 1983-05-09 1984-05-09
DE3490215A Expired - Lifetime DE3490215C2 (enExample) 1983-05-09 1984-05-09

Family Applications After (3)

Application Number Title Priority Date Filing Date
DE3448412A Expired - Lifetime DE3448412C2 (enExample) 1983-05-09 1984-05-09
DE3448360A Expired - Lifetime DE3448360C2 (enExample) 1983-05-09 1984-05-09
DE3490215A Expired - Lifetime DE3490215C2 (enExample) 1983-05-09 1984-05-09

Country Status (7)

Country Link
JP (3) JPH0610188B2 (enExample)
AU (1) AU568549B2 (enExample)
CH (1) CH665834A5 (enExample)
DE (4) DE3490215T (enExample)
DK (3) DK171397B1 (enExample)
NL (1) NL193245C (enExample)
WO (1) WO1984004527A1 (enExample)

Families Citing this family (20)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
JPS62500301A (ja) * 1984-10-04 1987-02-05 ウイスコンシン　アラムナイ　リサ−チ　フオンデ−シヨン ２４―ホモビタミンｄ誘導体
EP0211863B1 (en) * 1985-01-17 1992-12-30 Wisconsin Alumni Research Foundation Vitamin d derivatives and methods for preparing same
US5104864A (en) * 1988-08-02 1992-04-14 Bone Care International, Inc. Method for treating and preventing loss of bone mass
CA1341408C (en) * 1988-08-02 2002-12-10 Charles W. Bishop Method for treating and preventing loss of bone mass
US4973584A (en) * 1989-03-09 1990-11-27 Deluca Hector F Novel 1α-hydroxyvitamin D2 epimer and derivatives
JP2645130B2 (ja) * 1989-03-31 1997-08-25 日清製粉株式会社 ステロイド誘導体
GB8914963D0 (en) * 1989-06-29 1989-08-23 Leo Pharm Prod Ltd Chemical compounds
IN171449B (enExample) * 1990-02-14 1992-10-17 Wisconsin Alumni Res Found
DK0600079T3 (da) * 1992-06-22 2002-04-15 Bone Care Int Inc Oral 1alpha-hydroxyprævitamin D
US5795882A (en) * 1992-06-22 1998-08-18 Bone Care International, Inc. Method of treating prostatic diseases using delayed and/or sustained release vitamin D formulations
US5763429A (en) 1993-09-10 1998-06-09 Bone Care International, Inc. Method of treating prostatic diseases using active vitamin D analogues
US6242434B1 (en) 1997-08-08 2001-06-05 Bone Care International, Inc. 24-hydroxyvitamin D, analogs and uses thereof
US6573256B2 (en) 1996-12-30 2003-06-03 Bone Care International, Inc. Method of inhibiting angiogenesis using active vitamin D analogues
US6503893B2 (en) 1996-12-30 2003-01-07 Bone Care International, Inc. Method of treating hyperproliferative diseases using active vitamin D analogues
US6566353B2 (en) 1996-12-30 2003-05-20 Bone Care International, Inc. Method of treating malignancy associated hypercalcemia using active vitamin D analogues
NZ336924A (en) 1997-02-13 2001-06-29 Bone Care Int Inc Targeted therapeutic delivery of vitamin D compounds via a Vitamin D conjugate
JP2004504295A (ja) 2000-07-18 2004-02-12 ボーン　ケア　インターナショナル　インコーポレイテッド 安定化１α−ヒドロキシビタミンＤ
US7148211B2 (en) 2002-09-18 2006-12-12 Genzyme Corporation Formulation for lipophilic agents
US7094775B2 (en) 2004-06-30 2006-08-22 Bone Care International, Llc Method of treating breast cancer using a combination of vitamin D analogues and other agents
JP5492099B2 (ja) 2008-03-12 2014-05-14 シトクロマ インコーポレイテッド 安定化１，２５−ジヒドロキシビタミンｄ２及びその製造方法

Family Cites Families (3)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US4260549A (en) * 1979-05-21 1981-04-07 Wisconsin Alumni Research Foundation Process for preparing 1α-hydroxylated compounds
US4267117A (en) * 1978-06-19 1981-05-12 The Upjohn Company Compounds and process
US4269777A (en) * 1979-05-21 1981-05-26 Wisconsin Alumni Research Foundation Isotopically labeled vitamin D derivatives and processes for preparing same

Also Published As

Publication number Publication date
JPH0339505B2 (enExample) 1991-06-14
DE3448360C2 (enExample) 1991-10-02
CH665834A5 (de) 1988-06-15
DE3448412C2 (enExample) 1991-12-12
NL193245C (nl) 1999-04-02
AU3011584A (en) 1984-12-04
NL193245B (nl) 1998-12-01
JPH02288854A (ja) 1990-11-28
DK171397B1 (da) 1996-10-14
DK183291A (da) 1991-11-07
DK184588A (da) 1988-04-06
NL8420137A (nl) 1985-04-01
WO1984004527A1 (en) 1984-11-22
DK183291D0 (da) 1991-11-07
DK172733B1 (da) 1999-06-21
DK184588D0 (da) 1988-04-06
JPH0651624B2 (ja) 1994-07-06
DE3490215C2 (enExample) 1991-07-25
DK172567B1 (da) 1999-01-18
AU568549B2 (en) 1988-01-07
JPH0610188B2 (ja) 1994-02-09
JPH02288873A (ja) 1990-11-28
DK8685A (da) 1985-01-08
JPH02288829A (ja) 1990-11-28
DK8685D0 (da) 1985-01-08

Similar Documents

Publication Publication Date Title
DE3250034C2 (enExample)
DE3490215C2 (enExample)
DE60215225T2 (de) Alpha-hydroxy-2-methylen-10-nor-pregnacalciferol und seine anwendungen
US4588716A (en) Method for treating metabolic bone disease in mammals
DE60130640T2 (de) 2-alkylidene-19-nor-vitamin d verbindungen und ihre therapeutische verwendungen
DE2012167C2 (de) 25-Hydroxycholecalciferol-hydrat und Verfahren sowie Zwischenprodukte zu seiner Herstellung
DE3348322C2 (enExample)
DE69006052T2 (de) 19-Nor-Vitamin-D-Derivate.
DE69229103T2 (de) Verfahren zur herstellung und verwendung von 1alpha,24-dihydroxy vitamin-d2
DE60031666T2 (de) NICHT-CALCEMISCHE, TRANSKRIPTIONELL-AKTIVE, SCHWEFELHALTIGE ANALOGA VON 1-alpha, 25-DIHYDROXYVITAMIN D3 MIT ANTIPROLIFERATIVER WIRKUNG
EP0832063B1 (de) Vitamin d-derivate mit substituenten an c-25, verfahren zu ihrer herstellung, zwischenprodukte und die verwendung zur herstellung von arzneimitteln
DE3590232C2 (de) 1,24-Dihydroxy- 22-Vitamin D3-Derivate, diese enthaltende Arzneimittel sowie Cholesterinderivate alsZwischenprodukte
DE69300196T2 (de) 24-Cyclopropan-Vitamin-D-Derivate.
CH650237A5 (de) 1-fluorierte vitamin d verbindungen.
DE69410112T2 (de) 26,28-methylen-1alpha,25-dihydroxy-vitamin-d2-verbindungen
DE3490636C2 (de) Hydroxyvitamin D¶2¶-Isomere, Zwischenprodukt zu deren Herstellung und diese enthaltende pharmazeutische Zusammensetzungen
DE69325253T2 (de) 1alpha,24(s)-dihydroxy vitamin d2, seine synthese und verwendung
DE69712086T2 (de) Vitamin d derivate
DE69608701T2 (de) Vitamin d analoge
DE69634483T2 (de) Verwendung von 19-nor-vitamin-d-verbindungen zur vorbeugung von hyperphosphatemie bei nierenkrankheiten
DE69318142T2 (de) 1 alpha-HYDROXY-24-(EPI)-VITAMIN D4
DE19744127B4 (de) Neue Vitamin D-Derivate mit Cyclopropylringen in den Seitenketten, Verfahren und Zwischenprodukte zu ihrer Herstellung sowie ihre Verwendung zur Herstellung von Arzneimitteln
CH653995A5 (de) 2beta-fluorcholecalciferole.
DE3336292C2 (enExample)
DE10156596A1 (de) Vitamin D-Derivate mit Acyloxygruppen in der Seitenkette, Verfahren zu ihrer Herstellung und die Verwendung zur Herstellung von Arzneimitteln